The agency is requiring companies that make sartan blood pressure drugs to review their manufacturing processes due to the problem with impurities. / read more /
Nine award winners from the 2019 edition of Pharmapack Europe, covering innovations across drug delivery, packaging, and materials and components, have been announced by the event organizers. / read more /
The agency recommended six medicines for approval at its January 2019 meeting, including treatments for lung cancer, HIV-1, and autoimmune disorders. / read more /
The US Pharmacopeial Convention's new plan will include new and revised quality standards and activities to support the development of new generic drugs. / read more /
Radha Iyer, vice-president and head of Quality and Scientific Affairs, Global Developed Markets, Dr. Reddy's Laboratories, discusses new initiatives at the company. / read more /
Janssen and MeiraGTx will collaborate on the development and commercialization of gene therapies for treating inherited retinal diseases. / read more /
Intellectual challenge, work/life balance, compensation, and an unclear business outlook create uncertainty among European bio/pharma employees. / read more /
The LCMS–9030 of Shimadzu is a research grade mass spectrometer designed to deliver high-resolution, accurate mass detection with incredibly fast data acquisition rates, allowing scientists to identify and quantify more compounds with greater confidence. / Read more/
Date: 11 – 13 March 2019 Venue: Maritim proArte Hotel, Berlin, Germany Innovative solutions to the greatest challenges in pharmaceutical development
The DDF Summit brings together leading formulation development, drug delivery and device development professionals from both industry and academia to share and discuss their latest work. / Read more/
The editors explore new tools for bio/pharma lab studies—such as robotics, augmented reality, and advanced instrumentation— as well as best practices for method development, multiple attribute monitoring, lab mixers, and raw material testing.
